Potent antioxidative activity of lycopene: A potential role in scavenging hypochlorous acid

Free Radical Biology and Medicine

Volumn 49, Issue 2, 2010, Pages 205-213

  Pennathur, Subramaniam ^a   Maitra, Dhiman ^b   Byun, Jaeman ^a   Sliskovic, Inga ^b   Abdulhamid, Ibrahim ^c   Saed, Ghassan M ^b   Diamond, Michael P ^b   Abu Soud, Husam M ^b,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

Carotenoid oxidation; Free radicals; Hypochlorous acid; Lycopene; Myeloperoxidase

Indexed keywords

HYPOCHLOROUS ACID; LYCOPENE;

ANTIOXIDANT ACTIVITY; ARTICLE; COLOR; CONTROLLED STUDY; DRUG DEGRADATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; OXIDATION; PRIORITY JOURNAL; PROTECTION;

ANTIOXIDANTS; CARDIOVASCULAR DISEASES; CAROTENOIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FREE RADICAL SCAVENGERS; HYPOCHLOROUS ACID; INFLAMMATION; LYCOPERSICON ESCULENTUM; MASS SPECTROMETRY; OXIDATION-REDUCTION;

LYCOPERSICON ESCULENTUM;

EID: 77953543391     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.04.003     Document Type: Article

References (67)

1. Agarwal S., Rao A.V. Tomato lycopene and its role in human health and chronic diseases. Can. Med. Assoc. J. 2000, 163:739-744.
2. Khachik F., Carvalho L., Bernstein P.S., Muir G.J., Zhao D.Y., Katz N.B. Chemistry, distribution, and metabolism of tomato carotenoids and their impact on human health. Exp. Biol. Med. 2002, 227:845-851.
3. Matos H.R., Di Mascio P., Medeiros M.H. Protective effect of lycopene on lipid peroxidation and oxidative DNA damage in cell culture. Arch. Biochem. Biophys. 2000, 383:56-59.
4. Voutilainen S., Nurmi T., Mursu J., Rissanen T.H. Carotenoids and cardiovascular health. Am. J. Clin. Nutr. 2006, 83:1265-1271.
5. Dahan K., Fennal M., Kumar N.B. Lycopene in the prevention of prostate cancer. J. Soc. Integr. Oncol. 2008, 6:29-36.
6. Rao A.V. Lycopene, tomatoes, and the prevention of coronary heart disease. Exp. Biol. Med. (Maywood) 2002, 227:908-913.
7. Heber D. Colorful cancer prevention: alpha-carotene, lycopene, and lung cancer. Am. J. Clin. Nutr. 2000, 72:901-902.
8. Zhao Y.P., Yu W.L., Hu W.L., Ying Y. Anti-inflammatory and anticoagulant activities of lycopene in mice. Nutr. Res. 2003, 23:1591-1595.
9. Saedisomeolia A., Wood L.G., Garg M.L., Gibson P.G., Wark P.A. Lycopene enrichment of cultured airway epithelial cells decreases the inflammation induced by rhinovirus infection and lipopolysaccharide. J. Nutr. Biochem. 2009, 20:577-585.
10. Subhash K., Bose C., Agrawal B.K. Effect of short term supplementation of tomatoes on antioxidant enzymes and lipid peroxidation type-II diabetes. Indian J. Clin. Biochem. 2007, 22:95-98.
11. 2-induced oxidative injury and apoptosis in human endothelial cells. Cardiovasc. Drugs Ther. 2009, 23:439-448.
12. Mein J.R., Lian F., Wang X.-D. Biological activity of lycopene metabolites: implications for cancer prevention. Nutr. Rev. 2008, 66:667-683.
13. Zhang L.X., Cooney R.V., Bertramm J.S. Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: relationship to their cancer chemopreventive action. Carcinogenesis 1991, 12:2109-2114.
14. Klebanoff S.J. Oxygen metabolites from phagocytes. Inflammation: Basic Principles and Clinical Correlates 1999, 721-768. Philadelphia, Lippincott Williams & Wilkins. J.I. Gallin, R. Snyderman (Eds.).
15. Pullar J.M., Vissers M.C., Winterbourn C.C. Living with a killer: the effects of hypochlorous acid on mammalian cells. IUBMB Life 2000, 50:259-266.
16. Malech H.L., Gallin J.I. Neutrophils in human diseases. N. Engl. J. Med. 1987, 317:687-694.
17. Malle E., Buch T., Grone H.J. Myeloperoxidase in kidney disease. Kidney Int. 2003, 64:956-967.
18. Ohshima H., Tatemichi M., Sawa T. Chemical basis of inflammation-induced carcinogenesis. Arch. Biochem. Biophys. 2003, 417:3-11.
19. Schiller J., Fuchs B., Arnhold J., Arnold K. Contribution of reactive oxygen species to cartilage degradation in rheumatic diseases: molecular pathways, diagnosis and potential therapeutic strategies. Curr. Med. Chem. 2003, 20:2123-2145.
20. Hazen S.L., Heinecke J.W. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest. 1997, 99:2075-2081.
21. Goud A.P., Goud P.T., Diamond M.P., Gonik B., Abu-Soud H.M. Reactive oxygen species and oocyte aging: role of superoxide, hydrogen peroxide, and hypochlorous acid. Free Radic. Biol. Med. 2008, 44:1295-1304.
22. Prutz W.A. Hypochlorous acid interactions with thiols, nucleotides, DNA, and other biological substrates. Arch. Biochem. Biophys. 1996, 332:110-120.
23. Prutz W.A. Interactions of hypochlorous acid with pyrimidine nucleotides, and secondary reactions of chlorinated pyrimidines with GSH, NADH, and other substrates. Arch. Biochem. Biophys. 1998, 349:183-191.
24. Bergt C., Pennathur S., Fu X., Byun J., O'Brien K., McDonald T.O., Singh P., Anantharamaiah G.M., Chait A., Brunzell J., Geary R.L., Oram J.F., Heinecke J.W. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc. Natl. Acad. Sci. USA 2004, 101:13032-13037.
25. Winterbourn C.C., van den Berg J.J., Roitman E., Kuypers F.A. Chlorohydrin formation from unsaturated fatty acids reacted with hypochlorous acid. Arch. Biochem. Biophys. 1992, 296:547-555.
26. Zhang R., Brennan M.L., Shen Z., MacPherson J.C., Schmitt D., Molenda C.E., Hazen S.L. Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J. Biol. Chem. 2002, 277:46116-46122.
27. Candeias L.P., Patel K.B., Stratford M.R.L., Wardman P. Free hydroxyl radicals are formed on reaction between the neutrophil-derived species superoxide anion and hypochlorous acid. FEBS Lett. 1993, 333:151-153.
28. Long C.A., Bielski B.H.J. Rate of reaction of superoxide radical with chloride-containing species. J. Phys. Chem. 1980, 84:555-557.
29. Held A.M., Halko D.J., Hurst J.K. Mechanisms of chlorine oxidation of hydrogen peroxide. J. Am. Chem. Soc. 1978, 100:5732-5740.
30. Galijasevic S., Abdulhamid I., Abu-Soud H.M. Melatonin is a potent inhibitor for myeloperoxidase. Biochemistry 2008, 47:2668-2677.
31. Galijasevic S., Abdulhamid I., Abu-Soud H.M. Potential role of tryptophan and chloride in the inhibition of human myeloperoxidase. Free Radic. Biol. Med. 2008, 44:1570-1577.
32. Sliskovic I., Abdulhamid I., Sharma M., Abu-Soud H.M. Analysis of the mechanism by which tryptophan analogs inhibit human myeloperoxidase. Free Radic. Biol. Med. 2009, 47:1005-1013.
33. dos Anjos Ferreira A.L., Yeum K.J., Russell R.M., Krinsky N.I., Tang G. Enzymatic and oxidative metabolites of lycopene. J. Nutr. Biochem. 2004, 15:493-502.
34. Sutherland W.H., de Jong S.A., Walker R.J. Hypochlorous acid and low serum paraoxonase activity in haemodialysis patients: an in vitro study. Nephrol. Dial. Transplant. 2004, 19:75-82.
35. Kettle A.J., Winterbourn C.C. Assays for the chlorination activity of myeloperoxidase. Methods Enzymol. 1994, 233:502-512.
36. Sommerburg O., Langhans C.D., Arnhold J., Leichsenring M., Salerno C., Crifò C., Hoffmann G.F., Debatin K.M., Siems W.G. Beta-carotene cleavage products after oxidation mediated by hypochlorous acid-a model for neutrophil-derived degradation. Free Radic. Biol. Med. 2003, 35:1480-1490.
37. Pattison D.I., Hawkins C.L., Davies M.J. What are the plasma targets of the oxidant hypochlorous acid? A kinetic modeling approach. Chem. Res. Toxicol. 2009, 22:807-817.
38. Schaffer S.W., Azuma J., Mozaffari M. Role of antioxidant activity of taurine in diabetes. Can. J. Physiol. Pharmacol. 2009, 87:91-99.
39. Bouckenooghe T., Remacle C., Reusens B. Is taurine a functional nutrient?. Curr. Opin. Clin. Metab. Care 2006, 9:728-733.
40. Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. J. Natl. Cancer Inst. 1999, 91:317-331.
41. Arab L., Steck S. Lycopene and cardiovascular disease. Am. J. Clin. Nutr. 2000, 71:1691S-1695S.
42. Ben-Aziz A., Britton G., Goodwin T.W. Carotene epoxides of Lycopersicon esculentum. Phytochemistry 1973, 12:2759-2764.
43. Ukai N., Lu Y., Etoh H., Tagi A., Ina K., Oshima S., Ojima F., Sakamoto H., Ishiguro Y. Photosensitized oxygenation of lycopene. Biosci. Biotech. Biochem. 1994, 58:1718-1719.
44. Caris-Veyrat C., Schmid A., Carail M., Bohm V. Cleavage products of lycopene produced by in vitro oxidations: characterization and mechanisms of formation. J. Agric. Food Chem. 2003, 51:7318-7325.
45. Zhang H., Kotake-Nara E., Ono H., Nagao A. A novel cleavage product formed by autoxidation of lycopene induces apoptosis in HL-60 cells. Free Radic. Biol. Med. 2003, 35:1653-1663.
46. Kim S.-J., Nara E., Kobayashi H., Terao J., Nagao A. Formation of cleavage products by autoxidation of lycopene. Lipids 2001, 36:191-199.
47. Khachik F., Spangler C.J., Smith J.C., Canfield L.M., Steck A., Plander H. Identification, quantification, and relative concentrations of carotenoids and their metabolites in human milk and serum. Anal. Chem. 1997, 69:1873-1881.
48. Gajic M., Zaripheh S., Sun F., Erdman J.W. Apo-8′-lycopenal and apo-12′-lycopenal are metabolic products of lycopene in rat liver. J. Nutr. 2006, 136:1552-1557.
49. Hu X., White K.M., Jacobsen N.E., Mangelsdorf D.J., Canfield L.M. Inhibition of growth and cholesterol synthesis in breast cancer cells by oxidation products of β-carotene. J. Nutr. Biochem. 1998, 9:567-574.
50. Giovannucci E., Ascherio A., Rimn E.B., Stampfer M.J., Colditz G.A., Willett W.C. Intake of carotenoids and retinol in relation to risk of prostate cancer. J. Natl. Cancer Inst. 1995, 87:1767-1776.
51. Gann P.H., Ma J., Giovannucci E., Willett W., Sacks F.M., Hennekens C.H., Stampfer M.J. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res. 1999, 59:1225-1230.
52. Chen G., Djuric Z. Detection of 2, 6-cyclolycopene-1, 5-diol in breast nipple aspirate fluids and plasma: a potential marker of oxidative stress. Cancer Epidemiol. Biomarkers Prev. 2002, 11:1592-1596.
53. Freemantle S.J., Spinella M.J., Dmitrovsky E. Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 2003, 22:7305-7315.
54. Nara E., Hayashi H., Kotake M., Miyashita K., Nagao A. Acyclic carotenoids and their oxidation mixtures inhibit the growth of HL-60 human promyelocytic leukemia cells. Nutr. Cancer 2001, 39:273-283.
55. Kotake-Nara E., Kim S.J., Kobori M., Miyashita K., Nagao A. Acyclo-retinoic acid induces apoptosis in human prostate cancer cells. Anticancer Res. 2002, 22:689-695.
56. Aust O., Ale-Agha N., Zhang L., Wollersen H., Sies H., Stahl W. Lycopene oxidation product enhances gap junctional communication. Food Chem. Toxicol. 2003, 41:1399-1407.
57. Lian F., Smith D.E., Ernst H., Russell R.M., Wang X.-D. Apo-10′-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. Carcinogenesis 2007, 28:1567-1574.
58. Khachik F., Beecher G.R., Smith J.C. Lutein, lycopene, and their oxidative metabolites in chemoprevention of cancer. J. Cell. Biochem. Suppl. 1995, 22:236-246.
59. Henderson J.P., Byun J., Heinecke J.W. Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes produces 5-chlorocytosine in bacterial RNA. J. Biol. Chem. 1999, 274:33440-33448.
60. Nicholls S.J., Hazen S.L. Myeloperoxidase, modified lipoproteins, and atherogenesis. J. Lipid Res. 2009, 50. (Suppl).
61. Vivekanandan-Giri A., Wang J.H., Byun J., Pennathur S. Mass spectrometric quantification of amino acid oxidation products identifies oxidative mechanisms of diabetic end-organ damage. Rev. Endocr. Metab. Disord. 2008, 9:275-287.
62. Hazen S.L., Hsu F.F., Duffin K., Heinecke J.W. Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes converts low density lipoprotein cholesterol into a family of chlorinated sterols. J. Biol. Chem. 1996, 271:23080-23088.
63. Carr A.C., van den Berg J.J., Winterbourn C.C. Chlorination of cholesterol in cell membranes by hypochlorous acid. Arch. Biochem. Biophys. 1996, 332:63-69.
64. Pattison D.I., Hawkins C.L., Davies M.J. Hypochlorous acid-mediated oxidation of lipid components and antioxidants present in low-density lipoproteins: absolute rate constants, product analysis, and computational modeling. Chem. Res. Toxicol. 2003, 16:439-449.
65. Kawai Y., Kiyokawa H., Kimura Y., Kato Y., Tsuchiya K., Terao J. Hypochlorous acid-derived modification of phospholipids: characterization of aminophospholipids as regulatory molecules for lipid peroxidation. Biochemistry 2006, 45:14201-14211.
66. Pattison D.I., Davies M.J. Reactions of myeloperoxidase derived oxidants with biological substrates: gaining chemical insight into human inflammatory diseases. Curr. Med. Chem. 2006, 13:3271-3290.
67. Pitt A.R., Spickett C.M. Mass spectrometric analysis of HOCl- and free-radical-induced damage to lipids and proteins. Biochem. Soc. Trans. 2008, 36:1077-1082.